# Endothelial dysfunction and long-term survival in cardiovascular-kidney-metabolic syndrome stages 0-3: An EASIX-based national cohort study

Researcher: Ge Zhang
Chinese name: 张格
ORCID identity anchor: https://orcid.org/0000-0002-3116-3246
Canonical researcher: https://drgezhang.com/#person

Journal: Science Progress
Year: 2026
Type: Article
DOI: 10.1177/00368504261499186
Canonical page: https://drgezhang.com/papers/doi-10-1177-00368504261499186.html
Markdown record: https://drgezhang.com/papers/doi-10-1177-00368504261499186.md

## Full Authors

1. Asiya Abudesimu
2. Zhonghua Sun
3. Ge Zhang
4. Xiangyu Sun
5. Xinliang Peng
6. Dilixiati Siti
7. Xiang Ma

## About this record

This is an author-controlled publication record in the Ge Zhang Academic Hub. It identifies this work as part of Ge Zhang’s publication record via ORCID; the publisher version remains the version of record.

<a id="limited-evidence"></a>
## Author evidence note

### Research question and design

The study examined whether EASIX was associated with later mortality among 10,885 NHANES participants aged at least 30 years with cardiovascular-kidney-metabolic syndrome stages 0–3. It retrospectively analyzed survey cycles from 1999–2018, linking deaths through 2019. EASIX is calculated as lactate dehydrogenase multiplied by creatinine, divided by platelet count.

Source: [PubMed PMID 42893432, Abstract Objective and Methods: population, NHANES cycles, mortality linkage and EASIX definition.](https://pubmed.ncbi.nlm.nih.gov/42893432/)

### Principal quantitative findings

Over a median 97 months of follow-up, 1,122 participants died; 295 deaths were cardiovascular. Per one-unit higher EASIX, the adjusted hazard ratio was 1.41 (95% CI 1.24–1.61) for all-cause mortality and 1.30 (95% CI 1.13–1.49) for cardiovascular mortality. The abstract reports that the associations persisted after further lifestyle adjustment.

Source: [PubMed PMID 42893432, Abstract Results: follow-up, deaths, adjusted HRs and CIs, one-unit exposure scale and lifestyle adjustment.](https://pubmed.ncbi.nlm.nih.gov/42893432/)

### Cohort and model specification

Eligibility required a valid fasting-subsample weight and complete CKM-staging, EASIX, mortality-linkage and covariate information; participants were assigned their highest qualifying CKM stage, and stage 4 was excluded. Stage 3 included very-high-risk CKD or PREVENT 10-year total-CVD risk ≥20%; participants aged ≥80 years were assigned age 79 for PREVENT estimation. EASIX used LDH (U/L) × creatinine (mg/dL) / platelet count (10^9/L) and was modeled per one-unit increase and by quartiles. Analyses combined fasting-subsample weights with SDMVSTRA and SDMVPSU in survey-weighted Cox models. Model 2 added current smoking, BMI, systolic blood pressure, fasting glucose and antihypertensive, glucose-lowering and statin use to demographic adjustment. Follow-up ran from the baseline MEC examination to death or 31 December 2019; competing-risk analysis was a sensitivity analysis. These specifications support comparing cohort and model choices; the displayed Methods do not give the pooled-weight formula or exact cardiovascular-death codes.

Source: [Published article text displayed on ResearchGate, Materials and Methods Sections 2.1–2.5 (Study Design and Population through Statistical Analysis).](https://www.researchgate.net/publication/416242591_Endothelial_dysfunction_and_long-term_survival_in_cardiovascular-kidney-metabolic_syndrome_stages_0-3_An_EASIX-based_national_cohort_study)

### Scientific contribution and publication context

The analysis connects a composite endothelial-stress index with long-term outcomes among adults at CKM stages 0–3. It provides an observational comparator for epidemiologic discussions of endothelial stress, CKM staging and mortality; survey-weighted Cox models and spline analyses supply the reported association framework. Clinical risk-assessment use requires further validation. Electronic publication is recorded as 18 October 2026. The formal journal record is Science Progress, volume 109, issue 4 (2026), article 00368504261499186.

Source: [PubMed PMID 42893432, Abstract Methods and Conclusions: survey-weighted Cox models, restricted cubic splines, CKM stage scope and risk-assessment interpretation. PubMed ArticleDate DateType=Electronic 2026-10-18; Crossref volume 109, issue 4, article-number 00368504261499186 and published-print [2026,10].](https://pubmed.ncbi.nlm.nih.gov/42893432/)

### Evidence scope and limitations

Author-maintained explanation of an observational mortality analysis in CKM stages 0–3, supported by the indexed abstract and source-located reading of the published Methods.

- The retrospective cohort associations support epidemiologic comparison; they do not establish that changing EASIX changes mortality or that EASIX is an externally validated clinical prediction model.

### Provenance

- [Indexed cohort-study abstract and author metadata](https://pubmed.ncbi.nlm.nih.gov/42893432/) — PubMed XML abstract and bibliographic metadata; original paraphrase above. PMID 42893432, Abstract Objective/Methods/Results/Conclusions, AuthorList and ArticleDate.
- [Publisher-deposited citation record](https://api.crossref.org/works/10.1177/00368504261499186) — Crossref bibliographic metadata. DOI 10.1177/00368504261499186, volume, issue, article-number and publication dates.
- [Published article text and Methods on ResearchGate](https://www.researchgate.net/publication/416242591_Endothelial_dysfunction_and_long-term_survival_in_cardiovascular-kidney-metabolic_syndrome_stages_0-3_An_EASIX-based_national_cohort_study) — Published article text displayed publicly on ResearchGate; source-located Methods reading. The article frontmatter states CC BY-NC 4.0.. Same DOI and PMID; Materials and Methods Sections 2.1–2.5; original article license notice.

Source review: 2026-11-15.

## Cite this paper

Asiya Abudesimu, Zhonghua Sun, Ge Zhang, Xiangyu Sun, Xinliang Peng, Dilixiati Siti, Xiang Ma. Endothelial dysfunction and long-term survival in cardiovascular-kidney-metabolic syndrome stages 0-3: An EASIX-based national cohort study. Science Progress. 2026;109(4):00368504261499186. https://doi.org/10.1177/00368504261499186

- [BibTeX](https://drgezhang.com/citations/doi-10-1177-00368504261499186.bib)
- [RIS / EndNote](https://drgezhang.com/citations/doi-10-1177-00368504261499186.ris)
- [CSL JSON](https://drgezhang.com/citations/doi-10-1177-00368504261499186.csl.json)

## Links

- DOI: https://doi.org/10.1177/00368504261499186
- HTML page: https://drgezhang.com/papers/doi-10-1177-00368504261499186.html
- Google Scholar query: https://scholar.google.com/scholar?q=%22Endothelial%20dysfunction%20and%20long-term%20survival%20in%20cardiovascular-kidney-metabolic%20syndrome%20stages%200-3%3A%20An%20EASIX-based%20national%20cohort%20study%22
- ORCID: https://orcid.org/0000-0002-3116-3246
